FDA
label_change
· 2023-05-19
FDA Approved: LAMOTRIGINE — Supplemental Application (Actavis Pharma, Inc.)
Summary
The FDA approved a supplemental application for lamotrigine submitted by Actavis Pharma, Inc. The action pertains to updating or amending the drug's labeling un…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)